BCL2L1 and cancer: Concomitant inhibition of Mcl-1 and Bcl-xL is a highly effective strategy to destroy chemoresistant ovarian cancer cells, in accordance with previous studies we have conducted on cancer cells from other cancer sites [11;14;33].